BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,512,784 | -1.3% | 229,247 | +24.3% | 0.41% | +14.2% |
| Q2 2023 | $11,660,590 | +11.6% | 184,503 | -20.5% | 0.36% | +12.9% |
| Q1 2023 | $10,447,533 | +6.1% | 232,219 | +3.3% | 0.32% | +5.6% |
| Q4 2022 | $9,849,101 | +3.7% | 224,814 | +55.9% | 0.30% | -2.9% |
| Q3 2022 | $9,500,000 | +81.5% | 144,177 | +39.1% | 0.31% | +73.2% |
| Q2 2022 | $5,235,000 | -47.7% | 103,646 | -33.8% | 0.18% | -27.8% |
| Q1 2022 | $10,007,000 | +84.2% | 156,646 | +208.8% | 0.25% | +121.4% |
| Q4 2021 | $5,433,000 | +0.1% | 50,725 | -3.9% | 0.11% | +8.7% |
| Q3 2021 | $5,428,000 | -0.9% | 52,797 | -15.2% | 0.10% | +1.0% |
| Q2 2021 | $5,478,000 | -4.4% | 62,278 | +5.7% | 0.10% | -15.7% |
| Q1 2021 | $5,728,000 | -47.8% | 58,907 | -39.8% | 0.12% | -50.8% |
| Q4 2020 | $10,966,000 | -8.0% | 97,782 | -23.9% | 0.25% | -39.1% |
| Q3 2020 | $11,917,000 | +38.0% | 128,559 | +16.1% | 0.40% | +29.5% |
| Q2 2020 | $8,637,000 | – | 110,726 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |